Xpert SA Nasal Complete

Test. Inform. Manage.

"A rapid test for both SA and MRSA colonization has many applications, including assisting physicians in targeting appropriate prophylactic therapy and decolonization to reduce the risk of post-surgical site infections."
-Samir S. Awad M.D.
Associate Professor in the Michael E. DeBakey Dept. of Surgery, Baylor College of Medicine, Houston, Texas
Director of Surgical Intensive Care Unit, Veteran Affairs Medical Center, Houston

Runs On: GeneXpert^® System

The Need

Staphylococcus aureus infections are an increasingly serious public health issue.
Colonized patients at risk for serious complications include surgical, trauma, burn and dialysis patients:

• S. aureus colonized patients are up to 9 times more likely to develop surgical site infections than non-carriers
• S. aureus is the major cause of access infections and bacteremia in dialysis patients
• Carriage is the major risk factor for infection with
• S. aureus in dialysis patients
• Up to 93% of nosocomial S. aureus infections are caused by a patient’s own flora
• SA and MRSA infections are associated with increases in length of hospital stay, costs, morbidity, and mortality
• Nasal carriage of S. aureus and self-infection of wounds in ICU/Burn patients is well documented

The Solution

Rapid and accurate detection of colonization facilitates targeted infection control practices:

• Optimize pre-admission workflow and counseling
• Enables measures to reduce endogenous infection risk, including decolonization
• Supports measures to reduced exogenous infection risk, including barrier/contact precautions
• Aligns with infection control strategies as outlined by SCIP and SHEA/IDSA